|Dr. Douglas Murphy-Chutorian||CEO, Corp. Sec. & Director||721.98k||N/A||1954|
|Mr. Andrew B. Weinstein||Sr. VP of Fin. & Accounting||386.34k||N/A||1964|
|Dr. Herbert J. Semler||Founder & Chairman Emeritus||N/A||N/A||1928|
|Mr. Robert G. McRae||Chief Technical Officer||N/A||N/A||1969|
|Mr. Dennis Rosenberg||Chief Marketing Officer||N/A||N/A||1954|
Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
Semler Scientific, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.